Proair Respiclick
NDC Package 53002-1750-1

11-digit billing NDC: 53002175001

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Proair Respiclick is contraindicated in patients with a history of hypersensitivity to albuterol and/or severe hypersensitivity to milk proteins. Marketed by Rpk Pharmaceuticals, Inc., this product is identified by NDC 53002-1750 and is authorized under FDA application NDA205636.

Identification & Billing

NDC Package Code
53002-1750-1
Package Description
1 INHALER in 1 BOX / 200 POWDER, METERED in 1 INHALER
Product Code
11-Digit Billing Format
53002175001
RxNorm Crosswalk
  • RxCUI: 1649560 - albuterol sulfate 90 MCG/INHAL Dry Powder Inhaler, 200 Actuations
  • RxCUI: 1649560 - 200 ACTUAT albuterol 0.09 MG/ACTUAT Dry Powder Inhaler
  • RxCUI: 1649560 - albuterol 90 MCG/ACTUAT (albuterol sulfate 108 MCG/ACTUAT from mouthpiece) 200 ACTUAT Dry Powder Inhaler
  • RxCUI: 1649560 - albuterol 90 MCG/ACTUAT Dry Powder Inhaler, 200 ACTUAT
  • RxCUI: 1649961 - ProAir RespiClick 90 MCG/INHAL Dry Powder Inhaler, 200 Actuations

Clinical Specifications

Proprietary Name
Proair Respiclick
Dosage Form
-
Usage Information
PROAIR RESPICLICK is contraindicated in patients with a history of hypersensitivity to albuterol and/or severe hypersensitivity to milk proteins. Rare cases of hypersensitivity reactions, including urticaria, angioedema, and rash have been reported after the use of albuterol sulfate. There have been reports of anaphylactic reactions in patients using inhalation therapies containing lactose [see Warnings and Precautions (5.6)].

Regulatory & Marketing

Labeler Name
Rpk Pharmaceuticals, Inc.
FDA Application #
NDA205636
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
04-23-2015
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 53002-1750-1 identifies a specific commercial package of 1 inhaler in 1 box / 200 powder, metered in 1 inhaler of Proair Respiclick, labeled by Rpk Pharmaceuticals, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Rpk Pharmaceuticals, Inc. on April 23, 2015. The current certification is valid through December 31, 2024.

How is this Rpk Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 53002175001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
53002-1750-1
11-Digit CMS (5-4-2)
53002-1750-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.